ACSL4 overexpression was found to decrease GPX4 overexpression and increase ferroptosis marker levels, such as 5-hydroxyeicosatetraene (5-HETE), 12-HETE and 15-HETE, in glioma cells (31). Here, GPX4 is linked to central nervous system cancer.